Relmada Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $97.6M
Liabilities Breakdown FY2023
Total Liabilities: $12.2M
Asset Breakdown
Total Assets: $97.6M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $4.1M | 4.2% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $0 | 0.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $93.5M | 95.8% |
Liabilities Breakdown
Total Liabilities: $12.2M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.5M | 28.8% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $8.7M | 71.2% |